{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:07:11Z","timestamp":1789016831057,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["61325"],"award-info":[{"award-number":["61325"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"DOI":"10.1007\/s10096-026-05660-9","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:15:40Z","timestamp":1789013740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A multi-site observational study of rationality assessment for carbapenem use in China: carbapenem stewardship opportunities"],"prefix":"10.1007","author":[{"given":"Jingwen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guirong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"5660_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, Tangden T, Bitterman R, Bonomo RA, de Waele J, Daikos GL, Akova M, Harbarth S, Pulcini C, Garnacho-Montero J, Seme K, Tumbarello M, Lindemann PC, Gandra S, Yu Y, Bassetti M, Mouton JW, Tacconelli E, Rodriguez-Bano J (2022) European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine). Clin Microbiol Infect 28:521\u2013547","journal-title":"Clin Microbiol Infect"},{"key":"5660_CR2","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1128\/AAC.00296-11","volume":"55","author":"KM Papp-Wallace","year":"2011","unstructured":"Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA (2011) Carbapenems: past, present, and future. Antimicrob Agents Chemother 55:4943\u20134960","journal-title":"Antimicrob Agents Chemother"},{"key":"5660_CR3","unstructured":"World Health Organization (2017) Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Geneva, Switzerland"},{"key":"5660_CR4","unstructured":"World Health Organization (2021) Antimicrobial stewardship interventions: a practical guide. Geneva, Swizterland"},{"key":"5660_CR5","first-page":"1639","volume":"63","author":"ES Spivak","year":"2016","unstructured":"Spivak ES, Cosgrove SE, Srinivasan A (2016) Measuring appropriate antimicrobial use: attempts at opening the black box. Clin Infect Dis 63:1639\u20131644","journal-title":"Clin Infect Dis"},{"key":"5660_CR6","doi-asserted-by":"crossref","unstructured":"Jun HX, Zhixiang S, Chun W, Reksodiputro AH, Ranuhardy D, Tamura K, Matsumoto T, Lee DG, Purushotaman SV, Lim V, Ahmed A, Hussain Y, Chua M, Ong A, Liu CY, Hsueh PR, Lin SF, Liu YC, Suwangool P, Jootar S, Picazo JJ (2005) Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever. Int J Antimicrob Agents 26 Suppl 2:S128\u2013132; discussion S133\u2013140","DOI":"10.1016\/j.ijantimicag.2005.08.007"},{"key":"5660_CR7","unstructured":"China NHCo (2015) Guidance on Clinical Application of Antibacterial and Antifungal Agents. Beijing, China"},{"key":"5660_CR8","unstructured":"China NHCo (2018) Expert Consensus on Clinical Application of Carbapenems. Beijing, China"},{"key":"5660_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/QCO.0000000000000598","volume":"32","author":"S Corcione","year":"2019","unstructured":"Corcione S, Lupia T, Maraolo AE, Mornese Pinna S, Gentile I, De Rosa FG (2019) Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship. Curr Opin Infect Dis 32:663\u2013673","journal-title":"Curr Opin Infect Dis"},{"key":"5660_CR10","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1093\/jac\/dkx181","volume":"72","author":"APR Wilson","year":"2017","unstructured":"Wilson APR (2017) Sparing carbapenem usage. J Antimicrob Chemother 72:2410\u20132417","journal-title":"J Antimicrob Chemother"},{"key":"5660_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/cid\/ciab295","volume":"72","author":"PD Tamma","year":"2021","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ (2021) Infectious Diseases Society of America guidance on the treatment of extended-spectrum \u03b2-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis72:1109-1116.","journal-title":"Clin Infect Dis"},{"key":"5660_CR12","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1440-1681.1998.tb02179.x","volume":"25","author":"J Ludbrook","year":"1998","unstructured":"Ludbrook J (1998) Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25:1032\u20131037","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"5660_CR13","volume-title":"Categorical Data Analysis","author":"A Agresti","year":"2013","unstructured":"Agresti A (2013) Categorical Data Analysis, 3rd Edition. Wiley, Hoboken, NJ","edition":"3rd Edition"},{"key":"5660_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ijantimicag.2015.08.013","volume":"46","author":"R Gauzit","year":"2015","unstructured":"Gauzit R, Pean Y, Alfandari S, Bru JP, Bedos JP, Rabaud C, Robert J, Societe de Pathologie Infectieuse de Langue F, Observatoire National de l\u2019Epidemiologie de la Resistance Bacterienne aux A, Surveillance de la Prescription des Antibiotiques G (2015) Carbapenem use in French hospitals: a nationwide survey at the patient level. Int J Antimicrob Agents 46:707\u2013712","journal-title":"Int J Antimicrob Agents"},{"key":"5660_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eimc.2018.03.003","volume":"37","author":"S Grau","year":"2019","unstructured":"Grau S, Fondevilla E, Echeverria-Esnal D, Alcorta A, Limon E, Gudiol F, group VIP (2019) Widespread increase of empirical carbapenem use in acute care hospitals in Catalonia, Spain. Enferm Infecc Microbiol Clin 37:36\u201340","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"5660_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1586\/17512433.2016.1159129","volume":"9","author":"D Yoon","year":"2016","unstructured":"Yoon D, Koo HL, Choe PG, Song KH, Park WB, Bang JH, Kim ES, Park SW, Kim HB, Oh MD, Kim NJ (2016) The purpose and appropriateness of carbapenem use in a single university hospital, 2009\u20132013. Expert Rev Clin Pharmacol 9:863\u2013865","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5660_CR17","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s10096-024-04928-2","volume":"43","author":"G Ai","year":"2024","unstructured":"Ai G, Zhang Y, Guo K, Zhao L, Li Z, Hai H, Jia E, Liu J (2024) The impact of optimizing microbial diagnosis processes on clinical and healthcare economic outcomes in hospitalized patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 43:2147\u20132157","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5660_CR18","doi-asserted-by":"crossref","unstructured":"Liu W, Liao K, Wu J, Liu S, Zheng X, Wen W, Fu L, Fan X, Yang X, Hu X, Jiang Y, Wu K, Guo Z, Li Y, Liu W, Cai M, Guo Z, Guo X, Lu J, Chen E, Zhou H, Chen D (2024) Blood culture quality and turnaround time of clinical microbiology laboratories in Chinese Teaching Hospitals: A multicenter study. J Clin Lab Anal 38:e25008","DOI":"10.1002\/jcla.25008"},{"key":"5660_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nrmicro3068","volume":"11","author":"PE Fournier","year":"2013","unstructured":"Fournier PE, Drancourt M, Colson P, Rolain JM, La Scola B, Raoult D (2013) Modern clinical microbiology: new challenges and solutions. Nat Rev Microbiol 11:574\u2013585","journal-title":"Nat Rev Microbiol"},{"key":"5660_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ebiom.2017.04.032","volume":"19","author":"R Zhang","year":"2017","unstructured":"Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, Li Y, Liao K, Chen S (2017) Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine 19:98\u2013106","journal-title":"EBioMedicine"},{"key":"5660_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2147\/IJGM.S145133","volume":"10","author":"W Wanla","year":"2017","unstructured":"Wanla W, Katip W, Supakul S, Apiwatnakorn P, Khamsarn S (2017) Effects of an antimicrobial restriction system on appropriate carbapenem use in a hospital without infectious diseases consultation. Int J Gen Med 10:443\u2013449","journal-title":"Int J Gen Med"},{"key":"5660_CR22","doi-asserted-by":"crossref","unstructured":"Ayhan M, Coskun B, Kayaaslan B, Hasanoglu I, Kalem AK, Eser F, Bilir YA, Unlu S, Guner R (2024) Point prevalence of antibiotic usage in major referral hospital in Turkey. PLoS One, United States, p e0296900","DOI":"10.1371\/journal.pone.0296900"},{"key":"5660_CR23","doi-asserted-by":"crossref","unstructured":"Sadatsharifi A, Davarpanah MA, Namazi S, Mottaghi S, Mahmoudi L (2019) Economic Burden Of Inappropriate Empiric Antibiotic Therapy: A Report From Southern Iran. Risk Manag Healthc Policy, England, pp 339\u2013348","DOI":"10.2147\/RMHP.S222200"},{"key":"5660_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejim.2020.03.017","volume":"78","author":"A Faraone","year":"2020","unstructured":"Faraone A, Poggi A, Cappugi C, Tofani L, Riccobono E, Giani T, Fortini A (2020) Inappropriate use of carbapenems in an internal medicine ward: impact of a carbapenem-focused antimicrobial stewardship program. Eur J Intern Med 78:50\u201357","journal-title":"Eur J Intern Med"},{"key":"5660_CR25","doi-asserted-by":"crossref","unstructured":"Mogle BT, Seabury RW, Jones Z, Miller CD, Steele JM (2019) The Culture of Carbapenem Overconsumption: Where Does It Begin? Results of a Single-Center Survey. Hosp Pharm, United States, pp 175\u2013179","DOI":"10.1177\/0018578718775328"},{"key":"5660_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00134-019-05866-w","volume":"46","author":"A Tabah","year":"2020","unstructured":"Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J, Shorr AF, Leone M, Poulakou G, Depuydt P, Garnacho-Montero J (2020) Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med 46:245\u2013265","journal-title":"Intensive Care Med"},{"key":"5660_CR27","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","volume":"177","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE (2017) Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 177:1308\u20131315","journal-title":"JAMA Intern Med"},{"key":"5660_CR28","doi-asserted-by":"crossref","unstructured":"Bosetti D, Grant R, Catho G (2025) Computerized decision support for antimicrobial prescribing: what every antibiotic steward should know. Antimicrob Steward Healthc Epidemiol 5:e210","DOI":"10.1017\/ash.2025.10091"},{"key":"5660_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40121-025-01114-5","volume":"14","author":"DR Giacobbe","year":"2025","unstructured":"Giacobbe DR, Guastavino S, Marelli C, Murgia Y, Mora S, Signori A, Rosso N, Giacomini M, Campi C, Piana M, Bassetti M (2025) Antibiotics and artificial intelligence: clinical considerations on a rapidly evolving landscape. Infect Dis Ther 14:493\u2013500","journal-title":"Infect Dis Ther"},{"key":"5660_CR30","doi-asserted-by":"crossref","unstructured":"Abbas S (2024) The challenges of implementing infection prevention and antimicrobial stewardship programs in resource-constrained settings. Antimicrob Steward Healthc Epidemiol, England, p e45","DOI":"10.1017\/ash.2024.35"},{"key":"5660_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.21037\/hbsn-2024-754","volume":"14","author":"R Yan","year":"2025","unstructured":"Yan R, Sun M, Yang H, Du S, Sun L, Mao Y (2025) 2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges. Hepatobiliary Surg Nutr 14:66\u201377","journal-title":"Hepatobiliary Surg Nutr"},{"key":"5660_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1473-3099(20)30596-X","volume":"21","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wei L, Li H, Zhang M, Cao B, Bian J, Zhan S (2021) Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study. Lancet Infect Dis 21:847\u2013857","journal-title":"Lancet Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05660-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05660-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05660-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:15:45Z","timestamp":1789013745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05660-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":32,"alternative-id":["5660"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05660-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}